Evidence map›Paper›PMID 28932979›Full record

ReviewCurrent neurology and neuroscience reports2017

Tuberculous Meningitis in Children and Adults: New Insights for an Ancient Foe.

Alyssa Mezochow, Kiran Thakur, Christopher Vinnard

Abstract readReview
In one paragraph

Review in Current neurology and neuroscience reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Challenges in conducting trials for pediatric tuberculous meningitis: lessons from the field.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2019
    Trial
  5. Intrathecal Isoniazid and Dexamethasone Therapy May Improve Outcomes in Patients With Tuberculous Meningitis: A 2-Center Retrospective Cohort Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  6. Article
  7. Advanced Therapeutic Interventions TargetingArchives of Razi Institute · 2025
    Review
  8. Stroke from Infection.Cerebrovascular diseases extra · 2025
    Review
  9. Tuberculous meningitis leading to stroke: a case report.Annals of medicine and surgery (2012) · 2024
    Article
  10. Review
  11. Paediatric hydrocephalus.Nature reviews. Disease primers · 2024
    Review
  12. Review
  13. Article
  14. Acute ischemic stroke in tuberculous meningitis.Frontiers in public health · 2024
    Article
  15. Article
  16. Review
  17. Article
  18. MRI findings on extrapulmonary tuberculosis in a pediatric patientBiomedica : revista del Instituto Nacional de Salud · 2021
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Alyssa MezochowDrexel University College of Medicine, Philadelphia, PA, USA.
Kiran ThakurDepartment of Neurology, Columbia University Medical Center, New York, NY, USA.
Christopher VinnardPublic Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, 225 Warren Street, Newark, NJ, 07103, USA. cv274@njms.rutgers.edu.
Columbia University Irving Medical Center · USDrexel University · USRutgers, The State University of New Jersey · US

Funding

Rifampicin Malabsorption in HIV+ Patients: Mechanisms and Recovery after HAARTK23AI102639 · NIAID · RBHS-NEW JERSEY MEDICAL SCHOOL · PI VINNARD, CHRISTOPHER · 2014 to 2018
$695k
NIAID NIH HHS K23 AI102639
6 · The paper itself

Abstract

purpose of reviewTuberculous meningitis is the most devastating manifestation of infection with Mycobacterium tuberculosis and represents a medical emergency. Approximately one half of tuberculous meningitis patients die or suffer severe neurologic disability. The goal of this review will be to review the pathogenic, clinical, and radiologic features of tuberculous meningitis and to highlight recent advancements in translational and clinical science. RECENT

findingsPharmacologic therapy includes combination anti-tuberculosis drug regimens and adjunctive corticosteroids. It is becoming clear that a successful treatment outcome depends on an immune response that is neither too weak nor overly robust, and genetic determinants of this immune response may identify which patients will benefit from adjunctive corticosteroids. Recent clinical trials of intensified anti-tuberculosis treatment regimens conducted in Indonesia and Vietnam, motivated by the pharmacologic challenges of treating M. tuberculosis infections of the central nervous system, have yielded conflicting results regarding the survival benefit of intensified treatment regimens. More consistent findings have been observed regarding the relationship between initial anti-tuberculosis drug resistance and mortality among tuberculous meningitis patients. Prompt initiation of anti-tuberculosis treatment for all suspected cases remains a key aspect of management. Priorities for research include the improvement of diagnostic testing strategies and the optimization of host-directed and anti-tuberculosis therapies.

Indexed as

AdultAntitubercular AgentsChildHumansMycobacterium tuberculosisTreatment OutcomeTuberculosis, MeningealTuberculosis, Multidrug-ResistantAntitubercular AgentsCentral nervous system infectionsMeningitisMycobacterial infectionsTuberculosisTuberculous meningitis

Identifiers

PMID28932979
PMCPMC5729589
OpenAlexW2755528463

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.